29 September 2023
29 September 2023
The CMA quelled fears of competitor access to the patient record system being restricted after an investigation.
The extravascular implant is part of a short-term circulatory support device market estimated to reach $3.8bn by 2033.
The US FDA or any other regulatory entity has not yet approved the company’s products.
ClarityDX Prostate helps reduce prostate biopsies by up to 35%, thereby significantly reducing costs.
HarbingerHx uses machine learning and growing datasets to develop insights that increase clinical informativeness.
The system leverages AI-driven signal processing algorithms and enables the assessment of the individual’s coronary arteries.
The company’s algorithms put proteins through millions of years of simulated evolution to identify potential functional candidates.
ReGelTec aims to start enrolment in early 2024 for the trial evaluating its disc-mimicking hydrogel injecting system.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.
Give your business an edge with our leading industry insights.
